A hospital in Los Angeles, California is currently studying the possibility of treating the contagious and deadly coronavirus, a disease caused by a virus from China, through the use of ultraviolet light.
On April 20, pharmaceutical company Aytu Bioscience announced its exclusive license for worldwide rights to the Healight Platform Technology for research at Cedars-Sinai Medical Center in LA.
Although the Healigh technology is yet to be approved by the Food and Drug Administration, Aytu Bioscience said on its website that it’s working with the agency to develop an “expedited regulatory process” in order for it to be utilized sooner to aid COVID-19 patients in critical conditions.
In an email exchange with media company USA Today, Aytu Bioscience also said that it’s in the “preclinical stages of developing the technology, which eventually could be used to treat viruses and bacteria.”
“The technology has not been tested or used on patients,” the statement said. “Cedars-Sinai has filed for patents related to the technology and has signed a licensing agreement with Aytu Bioscience with the aim of potentially enabling near-term use as a COVID-19 intervention for critically ill, intubated patients,” the report from USA Today stated.
Using this technology, a catheter with LED lights that emit UV-A light will be inserted in a controlled way through a catheter.
While some researchers and medical professionals expressed concern over finding a way to use UV technology without harming the body, the administration of Cedars-Sinai Hospital mentioned that their team has already found means to do this while maintaining healthy cells.
“Our team has shown that administering a specific spectrum of UV-A light can eradicate viruses in infected human cells (including coronavirus) and bacteria in the area while preserving healthy cells,” said Dr. Mark Pimentel, the Executive Director of the Medically Associated Science and Technology Program of Cedars-Sinai Hospital.
Recently, Aytu Bioscience has also announced its collaboration with Sterling Medical Devices for the development of the technology.